Gilead Sciences Inc said on Wednesday it has started two late-stage studies to test its drug in patients with severe and moderate cases of the illness caused by the coronavirus, sending its shares up 4% in extended trading.
Reuters: World News, Reuters: World
Wed, 02/26/2020 - 3:52pm
Gilead Sciences Inc said on Wednesday it has started two late-stage studies to test its drug in patients with severe and moderate cases of the illness caused by the coronavirus, sending its shares up 4% in extended trading.